Discover and invest in PE funds and secondaries that match your investment strategy.
BioAsia Crossover Fund
by Vivo Capital
Overview of BioAsia Crossover Fund
BioAsia Crossover Fund is a closed private equity fund managed by Vivo Capital.
Access a unique secondary deal flow.
Find potential buyers without revealing your identity.
Already a member? Log in.
Manager of BioAsia Crossover Fund
Vivo Capital
United States
Vivo Capital is a private equity general partner firm headquartered in Palo Alto, CA, United States and has other offices in China.
Funds managed by Vivo Capital
| Fund name | Size | Vintage | Status |
|---|---|---|---|
| Vivo Capital Fund IX | USD 1,430m | 2019 | Closed |
| Vivo Capital Opportunity Fund | USD 635m | 2018 | Closed |
| Vivo Panda Fund I | USD 100m | 2016 | Closed |
| Vivo Capital Fund VIII | USD 750m | 2015 | Closed |
| Vivo Capital Surplus Fund VIII | USD 428m | 2015 | Closed |
| Vivo Ventures Fund VII | USD 375m | 2012 | Closed |
| Vivo Ventures (Chengdu) | USD 100m | 2010 | Closed |
| Vivo Ventures Fund VI | USD 275m | 2007 | Closed |
| Vivo Ventures Fund V | USD 179m | 2005 | Closed |
| BioAsia Crossover Fund | USD 15m | 2004 | Closed |
| Biotechnology Development Fund IV | - | 2003 | Closed |
| Biotechnology Development Fund I | - | 1997 | Liquidated |
| Biotechnology Development Fund II | - | - | Closed |
| Biotechnology Development Fund III | - | - | Closed |
Find and invest in PE funds and secondaries that match your investment strategy.
Already a member? Log in.